Correlation Between Neuropace and Telesis Bio
Can any of the company-specific risk be diversified away by investing in both Neuropace and Telesis Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and Telesis Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neuropace and Telesis Bio, you can compare the effects of market volatilities on Neuropace and Telesis Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of Telesis Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and Telesis Bio.
Diversification Opportunities for Neuropace and Telesis Bio
-0.53 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Neuropace and Telesis is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and Telesis Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Telesis Bio and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with Telesis Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Telesis Bio has no effect on the direction of Neuropace i.e., Neuropace and Telesis Bio go up and down completely randomly.
Pair Corralation between Neuropace and Telesis Bio
Given the investment horizon of 90 days Neuropace is expected to generate 10.55 times less return on investment than Telesis Bio. But when comparing it to its historical volatility, Neuropace is 6.92 times less risky than Telesis Bio. It trades about 0.16 of its potential returns per unit of risk. Telesis Bio is currently generating about 0.24 of returns per unit of risk over similar time horizon. If you would invest 155.00 in Telesis Bio on September 16, 2024 and sell it today you would earn a total of 143.00 from holding Telesis Bio or generate 92.26% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 23.08% |
Values | Daily Returns |
Neuropace vs. Telesis Bio
Performance |
Timeline |
Neuropace |
Telesis Bio |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Solid
Neuropace and Telesis Bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Neuropace and Telesis Bio
The main advantage of trading using opposite Neuropace and Telesis Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, Telesis Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telesis Bio will offset losses from the drop in Telesis Bio's long position.Neuropace vs. Avita Medical | Neuropace vs. Treace Medical Concepts | Neuropace vs. Inogen Inc | Neuropace vs. Apyx Medical |
Telesis Bio vs. GMS Inc | Telesis Bio vs. Cedar Realty Trust | Telesis Bio vs. Titan Machinery | Telesis Bio vs. CapitaLand Investment Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Transaction History View history of all your transactions and understand their impact on performance |